Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$800M |
| 2 |
NVIDIA
NVDA
|
+$304M |
| 3 |
Broadcom
AVGO
|
+$261M |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$656M |
| 2 |
Netflix
NFLX
|
+$632M |
| 3 |
Tesla
TSLA
|
+$474M |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.34% |
| 3 | Industrials | 11.14% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Vodafone
VOD
$38.2B
| $58.7M | 0.09% |
3,906,751
-841,056
| -18% | -$12.3M |
2015 Q3
42 quarters
|
|
277
Travere Therapeutics
TVTX
$4.91B
| $58.4M | 0.09% |
1,966,779
-280,000
| -12% | -$8.37M |
2019 Q1
28 quarters
|
|
278
Cigna
CI
$74.3B
| $58.4M | 0.09% |
218,939
+172,219
| +369% | +$47.6M |
2025 Q1
4 quarters
|
|
|
CPRX
279
DELISTED
Catalyst Pharmaceutical
CPRX
| $58.1M | 0.09% |
2,347,477
-302,600
| -11% | -$7.21M |
2021 Q3
18 quarters
|
|
280
Pinnacle West Capital
PNW
$11.9B
| $58M | 0.09% |
576,100
+162,700
| +39% | +$15.7M |
2013 Q4
49 quarters
|
|
281
BioMarin Pharmaceuticals
BMRN
$10.6B
| $57.9M | 0.09% |
1,024,871
-300,100
| -23% | -$17.5M |
2021 Q1
20 quarters
|
|
282
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.8B
| $57.8M | 0.09% |
530,436
+515,600
| +3,475% | +$60.3M |
2025 Q4
1 quarter
|
|
283
Alphabet (Google) Class C
GOOG
$4.22T
| $57.7M | 0.09% |
201,002
+98,921
| +97% | +$31.1M |
2025 Q3
2 quarters
|
|
284
Descartes Systems
DSGX
$6.96B
| $57.2M | 0.09% |
798,844
+125,900
| +19% | +$9.29M |
2013 Q2
51 quarters
|
|
285
AB InBev
BUD
$152B
| $56.3M | 0.09% |
810,874
+318,600
| +65% | +$23M |
2021 Q4
17 quarters
|
|
286
Aecom
ACM
$7.65B
| $56.2M | 0.09% |
662,277
+24,700
| +4% | +$2.34M |
2023 Q3
10 quarters
|
|
287
Regions Financial
RF
$23.1B
| $56M | 0.09% |
2,144,021
+597,600
| +39% | +$16.7M |
2025 Q3
2 quarters
|
|
288
Viking Holdings
VIK
$36.5B
| $55.8M | 0.09% |
759,204
-13,400
| -2% | -$979K |
2024 Q2
7 quarters
|
|
289
PTC
PTC
$21B
| $55.4M | 0.09% |
389,100
+183,600
| +89% | +$29M |
2025 Q4
1 quarter
|
|
290
Blue Owl Capital
OWL
$6.34B
| $55.4M | 0.09% |
6,065,200
+5,790,400
| +2,107% | +$70M |
2023 Q2
11 quarters
|
|
291
Takeda Pharmaceutical
TAK
$59.2B
| $55.4M | 0.09% |
2,989,100
+370,800
| +14% | +$6.51M |
2019 Q2
27 quarters
|
|
292
Madison Square Garden
MSGS
$9.8B
| $55.3M | 0.09% |
172,000
+54,100
| +46% | +$16.1M |
2020 Q4
21 quarters
|
|
293
Opendoor
OPEN
$2.22B
| $55.3M | 0.09% |
11,810,938
-27,519,500
| -70% | -$148M |
2022 Q2
15 quarters
|
|
294
Centene
CNC
$31.9B
| $55.2M | 0.09% |
1,684,669
+632,557
| +60% | +$25.9M |
2025 Q4
1 quarter
|
|
295
Crown Holdings
CCK
$11.8B
| $54.9M | 0.09% |
548,000
+70,300
| +15% | +$7.51M |
2023 Q3
10 quarters
|
|
296
Ezcorp Inc
EZPW
$1.92B
| $54.8M | 0.09% |
2,157,366
-196,862
| -8% | -$4.72M |
2015 Q2
43 quarters
|
|
297
Unity
U
$20.2B
| $54.5M | 0.09% |
+2,485,597
| New | +$68.9M |
2026 Q1
0 quarters
|
|
298
Gaming and Leisure Properties
GLPI
$11.1B
| $54.2M | 0.08% |
1,221,330
+575,000
| +89% | +$26.7M |
2024 Q3
6 quarters
|
|
299
AngloGold Ashanti
AU
$45.9B
| $54.2M | 0.08% |
+556,200
| New | +$57M |
2026 Q1
0 quarters
|
|
300
Carlisle Companies
CSL
$12.8B
| $53.9M | 0.08% |
161,460
+51,440
| +47% | +$18.7M |
2025 Q4
1 quarter
|
|
Similar funds
Renaissance Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Renaissance Technologies held 3,809 positions worth $63.9B, down 0.82% from $64.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2026 filing shows 624 new, 1,320 increased, 1,262 reduced and 596 closed positions. Its largest new stake was Apple: 3,075,638 shares worth $781M. The largest sale was Costco, an estimated $656M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Renaissance Technologies's largest Q1 2026 buy was Apple: 3,075,638 shares worth $781M.
- Renaissance Technologies added most to NVIDIA in Q1 2026, an estimated $304M increase.
- Renaissance Technologies's biggest Q1 2026 reduction was Costco, cutting an estimated $656M.
- Renaissance Technologies fully exited Procter & Gamble in Q1 2026, selling an estimated $428M.
- Renaissance Technologies's ten largest holdings make up 11% of its $63.9B portfolio in Q1 2026.
- Renaissance Technologies opened 624 new positions and closed 596 in Q1 2026.
- Renaissance Technologies's portfolio value fell 0.82% quarter-over-quarter to $63.9B.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.